{"id":"W2249669966","doi":"10.1182/blood.v106.11.350.350","title":"Mabthera (Rituximab) Plus CVP Chemotherapy for First-Line Treatment of Stage III/IV Follicular Non-Hodgkin’s Lymphoma (NHL): Confirmed Efficacy with Longer Follow-Up.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; International Prognostic Index; Surgery; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002512425,0.0004975626,0.00124241,0.0002874786,0.0002563144,0.0005495813,0.0004789896,0.0005111668,0.001989093],"category_scores_gemma":[0.001626752,0.0002456223,0.0009214069,0.0004165866,0.0003994111,0.0004955761,0.0003238283,0.001462299,0.0004032789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005825451,"about_ca_system_score_gemma":0.000472966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003509237,"about_ca_topic_score_gemma":0.0007449517,"domain_scores_codex":[0.9991407,0.0005022981,0.00004980886,0.0001080915,0.0001163517,0.00008270245],"domain_scores_gemma":[0.9990999,0.0002072464,0.0002764916,0.0001492526,0.00004880073,0.0002183614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5524753,0.01732992,0.04653952,0.001347588,0.004400811,0.0004435315,0.0002497175,0.001834849,0.03007429,0.0001452115,0.002954608,0.3422047],"study_design_scores_gemma":[0.2529608,0.4773987,0.2474663,0.0001452127,0.003637915,0.001782939,0.0000743315,0.00200096,0.007817999,0.0002657358,0.00639711,0.00005198755],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933677,0.004357266,0.0005344742,0.0001270438,0.00006774397,0.0004678794,0.0004229771,0.00002129611,0.0006336116],"genre_scores_gemma":[0.9947483,0.001583666,0.0007556769,0.0002461246,0.000160069,0.0006106998,0.001146918,0.000008954423,0.0007396236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002512425,"threshold_uncertainty_score":0.01328713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01676559784143811,"score_gpt":0.2686209798721655,"score_spread":0.2518553820307274,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}